Zimmer Biomet Holdings, Inc. (ZBH) Q2 2018 Earnings Results

Zimmer Biomet Holdings Beats on EPS, Stock Up 7.76%

Zimmer Biomet's strong EPS performance indicates effective cost management and operational efficiency. The stock's 7.76% increase reflects positive investor sentiment following the earnings report. However, the lack of revenue figures and guidance leaves some uncertainty about future growth prospects.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.92	N/A	+1.99%

Management

Management commentary

Tone: Confident

Management expressed confidence in the company's performance and highlighted ongoing efforts in product innovation. They emphasized their commitment to enhancing patient care.

We are pleased with our performance this quarter, particularly in our key product lines.

Our focus remains on innovation and improving patient outcomes.

Zimmer Biomet Holdings Beats on EPS, Stock Up 7.76%

Key numbers

Management commentary

Zimmer Biomet Holdings, Inc.

More earnings this week

Zimmer Biomet Holdings Beats on EPS, Stock Up 7.76%

Key numbers

Management commentary